Daniela Dimarco, MD

Articles by Daniela Dimarco, MD

Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC

ByAndrew J. Hale, MD,Daniela Dimarco, MD,John W. Ahern, PharmD*

May 29th 2019

This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.

Partial Oral Treatment of Infective Endocarditis Can Be Effective in Select Patients: Review of the POET Trial

ByAndrew J. Hale, MD,Daniela Dimarco, MD

September 20th 2018

By itself, the POET trial should not fundamentally change the current approach to infective endocarditis treatment.

Latest Updated Articles

Partial Oral Treatment of Infective Endocarditis Can Be Effective in Select Patients: Review of the POET Trial
Published: September 20th 2018 | Updated:
Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC
Published: May 29th 2019 | Updated:

Daniela Dimarco, MD

Articles by Daniela Dimarco, MD

Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC

Partial Oral Treatment of Infective Endocarditis Can Be Effective in Select Patients: Review of the POET Trial

Latest Updated Articles

Trending on Contagion Live

Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?

Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients

Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance

Emerging Diagnostic Tools and Mycobacterial Challenges in Skin and Soft Tissue Infections